Visualizar por Autor(es) 13354

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
Mostrando resultados del 1 al 20 de 36  >> Página siguiente
Fecha incorporaciónTítuloTipoAutor(es)
20111,4-Di-N-oxide quinoxaline-2-carboxamide: Cyclic voltammetry and relationship between electrochemical behavior, structure and anti-tuberculosis activityArticuloMoreno-Viguri, E. (Elsa); Perez-Silanes, S. (Silvia); Gouravaram, S. (S.), et al
20113-Trifluoromethylquinoxaline N,N’-Dioxides as Anti-trypanosomatid Agents. Identification of Optimal Anti-T. cruzi Derivatives and Mechanism of Action StudiesArticuloBenitez, D. (Diego); Cabrera, M. (M.); Hernández, P. (Paola), et al
2008An easy and direct method for the synthesis of 1,2,4-triazole derivatives through carboxylic acids and hydrazinophthalazineArticuloRivera, G. (Gildardo); Bocanegra-Garcia, V. (Virgilio); Moreno, A. (Antonio), et al
2008Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivativesArticuloBurguete, A. (Asunción); Estevez, Y. (Yannick); Castillo, D. (Denis), et al
2012Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives.ArticuloBarea, C. (Carlos); Pabon, A. (Adriana); Galiano, S. (Silvia), et al
2011Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationshipsArticuloMendoza, A. (Adela); Perez-Silanes, S. (Silvia); Quiliano, M. (Miguel), et al
2007Derivados de 1,4-di-N-óxido de quinoxalina y enfermedades olvidadasArticuloVicente, E. (Esther); Villar, R. (Raquel); Solano, B. (Beatriz), et al
2016Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosisArticuloSantivañez-Veliz, M. (Mery); Perez-Silanes, S. (Silvia); Torres, E. (Enrique), et al
2013Design, synthesis and study of quinoxaline-2- carboxamide 1,4-DI-N-Oxide derivatives as anti-tuberculosis agentsTesisMoreno-Viguri, E. (Elsa); Perez-Silanes, S. (Silvia); Monge, A. (Antonio)
2010Diseño, síntesis y evalación biológica de nuevos derivados de arilaminoalcoholes con potencial actividad contra la malariaTesisMendoza, A. (Adela); Perez-Silanes, S. (Silvia)
2008Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosisArticuloVicente, E. (Esther); Villar, R. (Raquel); Burguete, A. (Asunción), et al
2004Estudio in vivo de la oxidación mitocondrial en pacientes obesos tratados mediante restricción calóricaArticuloParra, M. D. (M.D.); Martinez-de-Morentin, B.E. (B.E.); Perez-Silanes, S. (Silvia), et al
2009Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.ArticuloAncizu, S. (Saioa); Moreno-Viguri, E. (Elsa); Torres, E. (Enrique), et al
2008In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxideArticuloVillar, R. (Raquel); Vicente, E. (Esther); Solano, B. (Beatriz), et al
2009New 1-aryl-3-substituted propanol derivatives as antimalarial agentsArticuloPerez-Silanes, S. (Silvia); Berrade, L. (Luis); Garcia–Sanchez, R.N. (Rory N.), et al
2011New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterieum tuberculosis agentsArticuloTorres, E. (Enrique); Moreno-Viguri, E. (Elsa); Ancizu, S. (Saioa), et al
20-feb-2010New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti- Mycobacterium tuberculosis agents.ArticuloMonge, A. (Antonio); Aldana, I. (Ignacio); Perez-Silanes, S. (Silvia), et al
2013New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activitiesArticuloBarea, C. (Carlos); Pabon, A. (Adriana); Perez-Silanes, S. (Silvia), et al
25-ene-2011New quinoxaline 1,4-di-N-oxide derivatives: Trypanosomaticidal activities and enzyme docking simulationArticuloEstevez, Y. (Yannick); Quiliano, M. (Miguel); Burguete, A. (Asunción), et al
2012New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.ArticuloAncizu, S. (Saioa); Castrillo, N. (Nerea); Perez-Silanes, S. (Silvia), et al